At the 'Spring Forward' earlier this year Apple had introduced ResearchKit, open source framework geared towards medical research. Since its official launch, however, ResearchKit has not received much attention from developers or medical research centers. A report by states that two large pharmaceutical companies are working on integrating ResearchKit into their clinical trials. One of the companies, GlaxoSmithKline, is one of the world's largest drug developers.
Now, at least two pharmaceutical companies are considering using ResearchKit in an effort for profit. 'GlaxoSmithKline', one of the largest drug developers in the world, is working on integrating ResearchKit into its clinical trials, and they want to start it in the coming months. The company says Apple's open source framework is a perfect way to improve patient participation and data collection.
It's true! We're looking @ Apple's #ResearchKit for clinical trials http://t.co/zZhLhXoKbf
- GSK (@GSK) July 10, 2015
Another pharmaceutical company 'Purdue pharma', he also said They are in the early stages of deciding whether Apple's ResearchKit is suitable for collecting data from their research from their medical trials or not.
People have been talking about it for a long time, but they haven't been able to find the perfect way to leverage the data and take advantage of it. ResearchKit is going to be a very significant milestone in the ability to move that data collection capacity.
Apple's main goal is for ResearchKit to have a significant impact on people's health And while that happens, the company provides pharmaceutical companies with this framework for their benefit. The Cupertino company, however, will regulate the applications containing ResearchKit in the App Store.